We are live on ! Find out more
ATRA icon

Atara Biotherapeutics
ATRA

111 hedge funds and large institutions have $535M invested in Atara Biotherapeutics in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 22 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more call options, than puts

Call options by funds: $717K | Put options by funds: $299K

123% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 22

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.22% less ownership

Funds ownership: 4.52% → 4.29% (-0.22%)

5% less funds holding

Funds holding: 117 → 111 (-6)

12% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 25

47% less capital invested

Capital invested by funds: $1.01B → $535M (-$472M)

Holders
111
Holders Change
-6
Holders Change %
-5.13%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
49
Reduced
22
Closed
25
Calls
$717K
Puts
$299K
Net Calls
+$418K
Net Calls Change
+$1.33M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$14.8M
2
AG
Artal Group
Luxembourg
+$9.52M
3
RG
Redmile Group
California
+$8.19M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$7.68M
5
Morgan Stanley
Morgan Stanley
New York
+$6.72M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$18.7M
2
WA
Wasatch Advisors
Utah
-$12.2M
3
BM
Bridger Management
New York
-$8.72M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$6.94M
5
CFM
Coronation Fund Managers
South Africa
-$3.26M
Name Holding Trade Value Shares
Change 		Change in
Stake
S
101
SignatureFD
Georgia
$3K +$4.44K +14 New
US Bancorp
102
US Bancorp
Minnesota
$2K -$1.27K -4 -31%
IA
103
IFP Advisors
Florida
$2K – – –
ST
104
Smithfield Trust
Pennsylvania
$2K – – –
IFAM
105
Institutional & Family Asset Management
Colorado
$1K – – –
SF
106
Synovus Financial
Georgia
$1K – – –
TWA
107
TCI Wealth Advisors
Arizona
$1K – – –
EI
108
Ellevest Inc
New York
$1K +$635 +2 +100%
PFO
109
Pathstone Family Office
New Jersey
$1K +$1.27K +4 New
TPCW
110
TD Private Client Wealth
New York
$247 +$317 +1 New
Assenagon Asset Management
111
Assenagon Asset Management
Luxembourg
– -$6.94M -16,849 Closed
CFM
112
Coronation Fund Managers
South Africa
– -$3.26M -7,927 Closed
Public Sector Pension Investment Board (PSP Investments)
113
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$2.63M -6,379 Closed
OAM
114
Oxford Asset Management
United Kingdom
– -$1.39M -3,363 Closed
GPP
115
Great Point Partners
Connecticut
– -$1.15M -2,800 Closed
Rafferty Asset Management
116
Rafferty Asset Management
New York
– -$1.04M -2,528 Closed
Jane Street
117
Jane Street
New York
– -$936K -2,273 Closed
ARTA
118
A.R.T. Advisors
New York
– -$900K -2,185 Closed
Russell Investments Group
119
Russell Investments Group
United Kingdom
– -$830K -2,021 Closed
HF
120
HRT Financial
New York
– -$807K -1,961 Closed
Ohio Public Employees Retirement System (OPERS)
121
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$654K -1,587 Closed
AG
122
Algert Global
California
– -$490K -1,190 Closed
6CM
123
683 Capital Management
New York
– -$412K -1,000 Closed
FAM
124
Fred Alger Management
New York
– -$247K -600 Closed
Creative Planning
125
Creative Planning
Kansas
– -$245K -594 Closed
2 3 4
5
6

ATRA Hedge Fund Activity: Q1 2020 in Review

111 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Atara Biotherapeutics (ATRA) for Q1 2020, worth a combined $535M — down 47% from $1.01B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ATRA and 22 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 49 added.

The largest buyer was Farallon Capital Management, adding an estimated $14.8M. The largest seller was Camber Capital Management, cutting an estimated $18.7M.

  • 111 institutional investors held Atara Biotherapeutics (ATRA) as of Q1 2020, down from 117 in Q4 2019.
  • Funds reported $535M of Atara Biotherapeutics stock for Q1 2020, down 47% quarter-over-quarter.
  • 22 funds opened new Atara Biotherapeutics positions in Q1 2020 and 25 closed out, a net change of -3 holders.
  • The largest Atara Biotherapeutics buyer in Q1 2020 was Farallon Capital Management, an estimated $14.8M added.
  • The largest Atara Biotherapeutics seller in Q1 2020 was Camber Capital Management, an estimated $18.7M sold.

Based on aggregated 13F filings for Q1 2020.